Treating Methicillin-Resistant Staphylococcus Aureus Infections with Compounded Vancomycin Preparations
Author(s): McElhiney Linda F
Issue: Mar/Apr 2009 - Sterile Compounding
View All Articles in Issue
Abstract: Methicillin-resistant Staphylococcus aureus infections have been an ongoing problem with institutions. Unfortunately, the problem has crossed over into the community setting. Drug resistance develops so rapidly that it is difficult for drug manufacturers to develop new treatment options in a timely manner. Compounding pharmacists can help physicians treat their methicillin-resistant Staphylococcus aureus patients by assisting them in developing new dosage forms or therapies to treat these difficult infections and providing patient counseling to prevent infection.
Related Categories: DERMATOLOGY, FORMULATIONS, CASE REPORTS, INFECTIOUS DISEASE
Purchase this article for download in electronic PDF format from IJPC at for $35 at:
Search the entire IJPC archive by keyword, topic, or issue at: